Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...
The CDC advises 45- to 75 year olds to get screened for colorectal cancer regularly. However, the American Cancer Society's statistics show that it is on the rise among people under the age of 50, ...
Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...